Cargando...
Repurposing of existing FDA approved drugs for Neprilysin inhibition: An in-silico study
Neprilysin (NEP) is a neutral endopeptidase with diverse physiological roles in the body. NEP's role in degradation of diverse classes of peptides such as amyloid beta, natriuretic peptide, substance P, angiotensin, endothelins, etc., is associated with pathologies of alzheimer's, kidney a...
Gardado en:
| Publicado en: | J Mol Struct |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Elsevier B.V.
2021
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7422802/ https://ncbi.nlm.nih.gov/pubmed/32834116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molstruc.2020.129073 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|